ARCHIVES

CALGB Grant OKed, But Group May Lose Support For Its Non-Hematologic Segments

This article is from The Cancer Letter archive.

Vol. 08 No. 02 | January 8, 1982

Download PDF Visit The Full Archive

Related Articles

Screening Guidelines: When Scientists Can’t Agree, What’s The Press To Do?

May 15, 1998

Low-Dose IFN Not Effective Against Melanoma, Study Finds

December 26, 2003

In Brief: San Antonia Cancer Institute Designated Comprehensive; Yeast DNA Described

May 3, 1996

ONS Congress Plans, Certification Exams Set For Pittsburgh

October 30, 1987

IVAX And It’s Portfolio

December 22, 1994

FDA Approves Mylotarg For First Relapse Of Acute Myeloid Leukemia In Patients 60+.

June 2, 2000